207 related articles for article (PubMed ID: 18330899)
41. A rare case of MYH9 disorders presenting with macrothrombocytopenia and deafness caused by MYH9-R702C mutation.
Kodama R; Taketani T; Kunishima S; Mishima S; Yoshikawa Y; Kanai R; Suyama T; Yoshino I; Kunishi H; Shibata H; Nagai A; Yamaguchi S; Masuda J
Thromb Res; 2009 Sep; 124(4):508-11. PubMed ID: 19250658
[No Abstract] [Full Text] [Related]
42. Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.
Lu W; Seeholzer SH; Han M; Arnold AS; Serrano M; Garita B; Philp NJ; Farthing C; Steele P; Chen J; Linask KK
Dev Dyn; 2008 Dec; 237(12):3577-90. PubMed ID: 18697221
[TBL] [Abstract][Full Text] [Related]
43. MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation.
Toren A; Rozenfeld-Granot G; Heath KE; Amariglio N; Rocca B; Crosson J; Epstein CJ; Laghi F; Landolfi R; Carlsson LE; Argraves S; Bizzaro N; Moxey-Mims M; Brok-Simoni F; Martignetti JA; Greinacher A; Rechavi G
Am J Hematol; 2003 Dec; 74(4):254-62. PubMed ID: 14635206
[TBL] [Abstract][Full Text] [Related]
44. Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.
Even-Ram S; Yamada KM
Cell Adh Migr; 2007; 1(3):152-5. PubMed ID: 19262128
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneous expression of nonmuscle myosin heavy chain-B in mesangial cells of patients with Gitelman's syndrome.
Sakumura T; Umemoto S; Fujii Z; Fujii K; Kawata Y; Minami M; Matsuzaki M
Clin Nephrol; 2001 Mar; 55(3):238-42. PubMed ID: 11316245
[TBL] [Abstract][Full Text] [Related]
46. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
[TBL] [Abstract][Full Text] [Related]
47. The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
Xiong D; Chen D; Liu D; Wu W; Dou X; Ji X; Li J; Zhang X
J Cancer; 2021; 12(14):4218-4228. PubMed ID: 34093822
[No Abstract] [Full Text] [Related]
48. Further evidence for the involvement of MYH9 in the etiology of non-syndromic cleft lip with or without cleft palate.
Birnbaum S; Reutter H; Mende M; de Assis NA; Diaz-Lacava A; Herms S; Scheer M; Lauster C; Braumann B; Schmidt G; Martini M; Hemprich A; Pötzsch S; Knapp M; Nöthen MM; Kramer FJ; Mangold E
Eur J Oral Sci; 2009 Apr; 117(2):200-3. PubMed ID: 19320731
[TBL] [Abstract][Full Text] [Related]
49. Expression of non-muscle myosin heavy chain in rat heart after immunosuppressive treatment.
Rezzani R; Pompili E; Agostini C; Buffoli B; Bonomini F; Nori S; Fumagalli L; Bianchi R
Int Immunopharmacol; 2006 Jun; 6(6):962-7. PubMed ID: 16644482
[TBL] [Abstract][Full Text] [Related]
50. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
[TBL] [Abstract][Full Text] [Related]
51. MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis.
Nangia-Makker P; Shekhar MPV; Hogan V; Balan V; Raz A
Oncotarget; 2022; 13():534-550. PubMed ID: 35309869
[TBL] [Abstract][Full Text] [Related]
52. An MYH9 human disease model in flies: site-directed mutagenesis of the Drosophila non-muscle myosin II results in hypomorphic alleles with dominant character.
Franke JD; Montague RA; Rickoll WL; Kiehart DP
Hum Mol Genet; 2007 Dec; 16(24):3160-73. PubMed ID: 17901043
[TBL] [Abstract][Full Text] [Related]
53. Mutations in MYH9 exons 1, 16, 26, and 30 are infrequently found in Japanese patients with nonsyndromic deafness.
Kunishima S; Matsunaga T; Ito Y; Saito H
Genet Test Mol Biomarkers; 2009 Oct; 13(5):705-7. PubMed ID: 19645626
[TBL] [Abstract][Full Text] [Related]
54. Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.
Kim KY; Kovács M; Kawamoto S; Sellers JR; Adelstein RS
J Biol Chem; 2005 Jun; 280(24):22769-75. PubMed ID: 15845534
[TBL] [Abstract][Full Text] [Related]
55. The irreversibility of platelet aggregation is regulated by myosin IIA, but is not compromised in MYH9-related disease.
Catricalà S; Guidetti GF; Canobbio I; Pecci A; Balduini CL; Balduini C; Torti M
Thromb Res; 2011 Feb; 127(2):171-3. PubMed ID: 20828798
[No Abstract] [Full Text] [Related]
56. Localization in stereocilia, plasma membrane, and mitochondria suggests diverse roles for NMHC-IIa within cochlear hair cells.
Lalwani AK; Atkin G; Li Y; Lee JY; Hillman DE; Mhatre AN
Brain Res; 2008 Mar; 1197():13-22. PubMed ID: 18241845
[TBL] [Abstract][Full Text] [Related]
57. The actomyosin network is influenced by NMHC IIA and regulated by Crp
Cao Y; Lei Y; Luo Y; Tan T; Du B; Zheng Y; Sun L; Liang Q
Exp Cell Res; 2018 Dec; 373(1-2):119-131. PubMed ID: 30336116
[TBL] [Abstract][Full Text] [Related]
58. Five (un)easy pieces: the MYH9-related giant platelet syndromes.
Martignetti J
Haematologica; 2002 Sep; 87(9):897-8. PubMed ID: 12217798
[No Abstract] [Full Text] [Related]
59. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
Ma ES; Wong CL; Shek TW; Hui SP
Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
[TBL] [Abstract][Full Text] [Related]
60. Nonmuscle myosin heavy chain and histone H3 are intracellular binding partners of lithospermic acid B and mediate its antiproliferative effect on VSMCs.
Cho YH; Lim EY; Kim JM; Jung M; Lee HC; Seo M; Lee EJ
Curr Med Chem; 2012; 19(11):1731-7. PubMed ID: 22257061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
